Voiding Dysfunction in Patients With Advanced Pelvic Organ Prolapse and Bladder Outlet Obstruction Following Pelvic Reconstructive Surgery: Urodynamic Profile and Predictive Risk Factors.
TL;DR
Voiding Dysfunction may persist in women with BOO following PRS, particularly in those with pre-operative maximal cystometric capacity (MCC) of >500ml and post-void residual volume > 200ml, and univariate and multivariate logistic regression reveals factors associated with post-operative VD are pre-operatively MCC ≥500 ml and PVR ≥ 200ml.
📈 연도별 인용 (2025–2026) · 합계 4
OpenAlex 토픽 ·
Pelvic floor disorders treatments
Urinary Bladder and Prostate Research
Urinary Tract Infections Management
【연구 목적】 요도 폐색(BOO)이 동반된 중증 골반 장기 탈출증(Pelvic Organ Prolapse, POP) 환자에서 골반 재건 수술(Pelvic Reconstructive Surgery, PRS) 후 배뇨 기능 회복 여부와 지속성 배뇨 장애(Voiding Dysfunction, VD)의 예측 인자를 규명하는 것.
- 표본수 (n) 392
- 연구 설계 cohort study
APA
Tsia‐Shu Lo, Fazlin Harun, et al. (2024). Voiding Dysfunction in Patients With Advanced Pelvic Organ Prolapse and Bladder Outlet Obstruction Following Pelvic Reconstructive Surgery: Urodynamic Profile and Predictive Risk Factors.. Journal of minimally invasive gynecology, 31(2), 102-109. https://doi.org/10.1016/j.jmig.2023.11.003
MLA
Tsia‐Shu Lo, et al.. "Voiding Dysfunction in Patients With Advanced Pelvic Organ Prolapse and Bladder Outlet Obstruction Following Pelvic Reconstructive Surgery: Urodynamic Profile and Predictive Risk Factors.." Journal of minimally invasive gynecology, vol. 31, no. 2, 2024, pp. 102-109.
PMID
37952873
Abstract
[STUDY OBJECTIVE] To determine the outcome of voiding function 1 year after pelvic reconstructive surgery (PRS) in women with bladder outlet obstruction (BOO).
[DESIGN] Retrospective cohort study.
[SETTING] Tertiary referral hospital.
[PATIENTS] A total of 1894 women underwent PRS for advanced pelvic organ prolapse (POP) stages 3 to 4 with urodynamic findings of BOO.
[INTERVENTIONS] PRS.
[MEASUREMENTS] The primary outcome measured was the resumption of normal voiding function, defined clinically with multichannel urodynamic testing at 1 year postoperatively. The secondary outcomes were to identify the different risk factors for persistence voiding dysfunction (VD) 1 year after PRS.
[MAIN RESULTS] A total of 431 women with Pelvic Organ Prolapse Quantification stages 3 and 4, urodynamic study of maximum urinary flow rate ≤15 mL/s, and detrusor pressure at maximum flow ≥20 cm HO were included. Resumption of normal voiding function was found in 91% (n = 392 of 431), whereas 9% (n = 39 of 431) remained to have VD 1 year postoperatively. Those with persistent VD, 20.5% (n = 8 of 39) remained having urodynamic diagnosis of BOO. Univariate and multivariate logistic regression revealed factors associated with postoperative VD were pre-operative maximal cystometric capacity ≥500 mL and postvoid residual volume ≥200 mL.
[CONCLUSION] VD may persist in women with BOO after PRS, particularly in those with preoperative maximal cystometric capacity of >500 mL and postvoid residual volume >200 mL.
[DESIGN] Retrospective cohort study.
[SETTING] Tertiary referral hospital.
[PATIENTS] A total of 1894 women underwent PRS for advanced pelvic organ prolapse (POP) stages 3 to 4 with urodynamic findings of BOO.
[INTERVENTIONS] PRS.
[MEASUREMENTS] The primary outcome measured was the resumption of normal voiding function, defined clinically with multichannel urodynamic testing at 1 year postoperatively. The secondary outcomes were to identify the different risk factors for persistence voiding dysfunction (VD) 1 year after PRS.
[MAIN RESULTS] A total of 431 women with Pelvic Organ Prolapse Quantification stages 3 and 4, urodynamic study of maximum urinary flow rate ≤15 mL/s, and detrusor pressure at maximum flow ≥20 cm HO were included. Resumption of normal voiding function was found in 91% (n = 392 of 431), whereas 9% (n = 39 of 431) remained to have VD 1 year postoperatively. Those with persistent VD, 20.5% (n = 8 of 39) remained having urodynamic diagnosis of BOO. Univariate and multivariate logistic regression revealed factors associated with postoperative VD were pre-operative maximal cystometric capacity ≥500 mL and postvoid residual volume ≥200 mL.
[CONCLUSION] VD may persist in women with BOO after PRS, particularly in those with preoperative maximal cystometric capacity of >500 mL and postvoid residual volume >200 mL.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | detrusor
|
scispacy | 1 | ||
| 약물 | PRS
→ pelvic reconstructive surgery
|
C0524865
Reconstructive Surgical Procedures
|
scispacy | 1 | |
| 약물 | BOO
→ bladder outlet obstruction
|
C0005694
Bladder neck obstruction
|
scispacy | 1 | |
| 약물 | [STUDY OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | [MAIN RESULTS] A
|
scispacy | 1 | ||
| 약물 | urinary
|
scispacy | 1 | ||
| 약물 | [CONCLUSION] VD
|
scispacy | 1 | ||
| 질환 | Pelvic Organ Prolapse
|
C0877015
Pelvic Organ Prolapse
|
scispacy | 1 | |
| 질환 | Bladder Outlet Obstruction
|
C0005694
Bladder neck obstruction
|
scispacy | 1 | |
| 질환 | PRS
→ pelvic reconstructive surgery
|
C0524865
Reconstructive Surgical Procedures
|
scispacy | 1 | |
| 질환 | BOO
→ bladder outlet obstruction
|
C0005694
Bladder neck obstruction
|
scispacy | 1 | |
| 질환 | voiding dysfunction
|
scispacy | 1 | ||
| 질환 | Bladder Outlet
|
scispacy | 1 | ||
| 질환 | Pelvic Organ
|
scispacy | 1 | ||
| 기타 | women
|
scispacy | 1 | ||
| 기타 | BOO
→ bladder outlet obstruction
|
scispacy | 1 |
MeSH Terms
Humans; Female; Urinary Bladder Neck Obstruction; Retrospective Studies; Urodynamics; Surgery, Plastic; Pelvic Organ Prolapse; Risk Factors